Reversal of Neuromuscular Blockade
📧 Sign up to get email alerts when something new happens for Reversal of Neuromuscular Blockade.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-02-23FDA Approved: PREVDUO — Original Application (Endo USA)
The FDA approved PREVDUO, a fixed-dose combination of neostigmine methylsulfate and glycopyrrolate, under an original NDA for reversal of ne…
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145) [Phase 4]
Phase 4 clinical trial update assessing the safety of sugammadex for reversing neuromuscular blockade in ASA class 3 or 4 participants.